Peyronies Disease Treatment Market Report 2026

Peyronies Disease Treatment Market Overview

• Peyronies Disease Treatment market size has reached to $1.05 billion in 2025 • Expected to grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 10.5% • Growth Driver: Rising Focus On Men’s Health Driving The Market Growth Due To Increasing Awareness And Early Diagnosis Of Male-Specific Conditions • Market Trend: Innovation In Spatial Computing Advances Precision Training For Minimally Invasive Injectable Therapies • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Peyronies Disease Treatment Market?

Peyronie’s disease treatment refers to medical and therapeutic approaches used to manage a condition characterized by the development of fibrous scar tissue inside the penis, which can cause curvature, pain, and difficulty during function. These treatments aim to reduce plaque formation, improve curvature, alleviate discomfort, and restore functional performance through pharmaceutical, surgical, and non-surgical interventions. It supports improved patient outcomes through specialized healthcare procedures, therapeutic devices, and clinical management solutions. The main treatment types of peyronies disease treatment include non surgical treatments and surgical treatments. Non surgical treatments refer to therapeutic approaches such as medications, injections, topical therapies, and medical devices used to reduce penile curvature and associated symptoms without surgery. These treatments are administered through oral, injectable, topical, and device based or external routes and they are utilized by end users including hospitals, specialty clinics, ambulatory surgical centers, and others.

What Is The Peyronies Disease Treatment Market Growth Forecast?

The peyronies disease treatment market size is expected to see rapidly grown in the next few years. It will grow to $1.73 billion in 2030 at a compound annual growth rate (CAGR) of 10.5%. The growth in the forecast period can be attributed to increasing development of novel antifibrotic drug therapies and biologics, rising demand for non-invasive and outpatient treatment options, growing clinical research into regenerative medicine approaches for penile tissue repair, increasing patient preference for combination therapy protocols, expanding healthcare access and reimbursement support for men’s health treatments. Major trends in the forecast period include oral pharmacological therapy expansion, rising adoption of collagenase injection-based treatments for plaque reduction, increasing preference for penile traction device therapy in curvature correction, growing utilization of low-intensity shockwave therapy for pain and fibrosis management, expanding shift toward minimally invasive surgical correction and combination therapy approaches.

Global Peyronies Disease Treatment Market Segmentation

1) By Treatment Type: Non Surgical Treatments; Surgical Treatments 2) By Route Of Administration: Oral; Injectable; Topical; Device Based Or External 3) By End User: Hospitals; Specialty Clinics; Ambulatory Surgical Centers; Other End Users Subsegments: 1) By Non Surgical Treatments: Oral Drug Therapy Treatments; Intralesional Injection Therapy Treatments; Shockwave Therapy Treatments; Traction Device Therapy Treatments 2) By Surgical Treatments: Plication Surgery Treatments; Grafting Surgery Treatments; Penile Prosthesis Implant Surgery Treatments; Plaque Incision And Excision Surgery Treatments

What Is The Driver Of The Peyronies Disease Treatment Market?

The rising focus on men’s health is expected to propel the growth of the peyronies disease treatment market going forward. Men’s health refers to the physical, mental, and reproductive well-being of males and the prevention, diagnosis, and treatment of conditions that specifically or predominantly affect them. The focus on men’s health is growing due to increasing awareness of male-specific diseases as more people and healthcare systems are recognizing conditions that uniquely affect men, leading to earlier diagnosis, better education, and improved access to targeted medical care. Focus on men’s health drives peyronie’s disease treatment by encouraging greater awareness, earlier diagnosis, and increasing willingness among men to seek medical consultation for urological conditions, which ultimately leads to higher adoption of specialized therapies and improved treatment outcomes. For instance, in July 2025, according to the Local Government Association, a UK-based organization, more than 2.74 million individuals accessed sexual health clinics in England in 2023, with men representing over 60% of all new sexually transmitted infection (STI) diagnoses in the country. Therefore, the rising focus on men’s health is driving the growth of the peyronies disease treatment industry.

Key Players In The Global Peyronies Disease Treatment Market

Major companies operating in the peyronies disease treatment market are Keenova Therapeutics plc; Coloplast A/S; Boston Scientific Corporation; Viatris Inc.

Global Peyronies Disease Treatment Market Trends and Insights

Major companies operating in the peyronies disease treatment market are focusing on developing innovative solutions, such as mixed reality injection training platforms, to enhance physician training, improve injection accuracy, and support safer and more effective treatment outcomes. Mixed reality injection training platforms are immersive medical training systems that combine virtual 3D anatomy with real-world interaction to simulate injection procedures, helping clinicians practice techniques in a risk-free environment to improve accuracy, confidence, and patient safety during actual treatments. For instance, in April 2025, Endo Pharmaceuticals, a US-based pharmaceutical company, launched Endo’s Spatial Computing Injection Simulator for Peyronie’s disease, an innovative training solution. The product integrates immersive spatial computing environments, anatomically accurate 3D modeling, and guided procedural workflows to simulate intralesional injection techniques used in clinical management of Peyronie’s disease. It enables healthcare professionals to rehearse patient-specific injection scenarios, improves understanding of plaque localization and curvature correction strategies, and reduces variability in real-world procedures through repetitive, risk-free practice. The simulator also supports standardized medical training across institutions, helping expand access to advanced Peyronie’s disease therapies by improving clinician proficiency and procedural consistency.

What Are Latest Mergers And Acquisitions In The Peyronies Disease Treatment Market?

In July 2025, Mallinckrodt plc, an Ireland-based pharmaceutical company, acquired Endo Inc. for $6.7 billion. With this acquisition, Mallinckrodt and Endo aim to combine complementary branded and generics portfolios, strengthening their ability to deliver patient-focused therapies and expand access to essential medicines, while improving supply chain efficiency and enhancing global market reach to better serve patients across high-need therapeutic areas. Endo Inc. is a US-based pharmaceutical company specializing in providing treatment for peyronie’s disease.

Regional Outlook

North America was the largest region in the peyronies disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Peyronies Disease Treatment Market?

The peyronie’s disease treatment market consists of revenues earned by entities by providing services such as diagnostic evaluation, drug therapy, injectable treatments, shockwave therapy, surgical correction procedures, rehabilitation therapy, and patient consultation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The peyronie’s disease treatment market also includes sales of oral medications, injectable biologics, traction devices, vacuum therapy devices, surgical instruments, and related therapeutic equipment. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Peyronies Disease Treatment Market Report 2026?

The peyronies disease treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the peyronies disease treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.